Kamila Kebaili

Lyon, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Albumin priming enables safe and effective red blood cell exchange in low-weight children with sickle cell disease.

Albumin priming enables safe and effective red blood cell exchange in low-weight children with sickle cell disease.

Journal: Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine

Published: May 05, 2026

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Splenectomy in β-thalassemia patients: Practices and risks in a nationwide study.

Journal: HemaSphere

Published: November 26, 2025

New Insights Into Infections' Risk of Adolescents and Young Adults Treated for Acute Lymphoblastic Leukemia.

New Insights Into Infections' Risk of Adolescents and Young Adults Treated for Acute Lymphoblastic Leukemia.

Journal: The Pediatric infectious disease journal

Published: July 31, 2024

Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.

Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.

Journal: Haematologica

Published: September 20, 2023

Priming With Red Blood Cells Allows Red Blood Cell Exchange for Sickle Cell Disease in Low-Weight Children.

Priming With Red Blood Cells Allows Red Blood Cell Exchange for Sickle Cell Disease in Low-Weight Children.

Journal: Frontiers in medicine

Published: July 18, 2021

Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without α-thalassaemia.

Comparisons of oxygen gradient ektacytometry parameters between sickle cell patients with or without α-thalassaemia.

Journal: British journal of haematology

Published: May 19, 2021

Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease.

Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease.

Journal: Cells

Published: March 08, 2021

Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort study.

Childhood Langerhans cell histiocytosis with severe lung involvement: a nationwide cohort study.

Journal: Orphanet journal of rare diseases

Published: April 06, 2020

Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment.

Long-term follow-up of children with risk organ-negative Langerhans cell histiocytosis after 2-chlorodeoxyadenosine treatment.

Journal: British journal of haematology

Published: March 10, 2020

Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major.

Goal-Oriented Monitoring of Cyclosporine Is Effective for Graft-versus-Host Disease Prevention after Hematopoietic Stem Cell Transplantation in Sickle Cell Disease and Thalassemia Major.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: April 16, 2019

Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients.

Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients.

Journal: Transfusion

Published: August 10, 2018

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.

Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study.

Journal: British journal of haematology

Published: May 16, 2018

Showing 1-12 of 24

Last Updated: 09/26/2026